Hence, the present study aimed to investigate the role of TMEM170B as a prognostic biomarker and therapeutic target in pancreatic cancer and explore the possible underlying mechanisms of TMEM170B in the development of pancreatic cancer. The gene discussed is TMEM170B; the disease is familial pancreatic carcinoma.